Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

CytomX Therapeutics, Inc. (CTMX)

Add CTMX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/4/2017 10:18:27 AM - Followers: 3 - Board type: Free - Posts Today: 0

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and The University of Texas M. D. Anderson Cancer Center to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTMX News: Current Report Filing (8-k) 08:07 AM
CTMX News: CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjuga... 08:00 AM
CTMX News: Current Report Filing (8-k) 06/28/2017 08:06:21 AM
CTMX News: CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-CX-2009 Trial 06/28/2017 08:00:00 AM
CTMX News: Statement of Changes in Beneficial Ownership (4) 06/27/2017 04:58:40 PM
News News Alert: Current Report Filing (8-k) 06/29/2017 08:07:03 AM